From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria
Abstract Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and herit...
Saved in:
Published in | Human molecular genetics Vol. 27; no. 7; pp. 1164 - 1173 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.04.2018
Oxford University Press (OUP) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability. |
---|---|
AbstractList | Abstract
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability. Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability. Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability.Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene. AIP is thought to display autosomal dominant inheritance with incomplete penetrance. We evaluated the prevalence, penetrance and heritability of AIP, in families with the disease from the French reference center for porphyria (CFP) (602 overt patients; 1968 relatives) and the general population, using Exome Variant Server (EVS; 12 990 alleles) data. The pathogenicity of the 42 missense variants identified was assessed in silico, and in vitro, by measuring residual HMBS activity of the recombinant protein. The minimal estimated prevalence of AIP in the general population was 1/1299. Thus, 50 000 subjects would be expected to carry the AIP genetic trait in France. Penetrance was estimated at 22.9% in families with AIP, but at only 0.5-1% in the general population. Intrafamily correlation studies showed correlations to be strong overall and modulated by kinship and the area in which the person was living, demonstrating strong influences of genetic and environmental modifiers on inheritance. Null alleles were associated with a more severe phenotype and a higher penetrance than for other mutant alleles. In conclusion, the striking difference in the penetrance of HMBS mutations between the general population and the French AIP families suggests that AIP inheritance does not follow the classical autosomal dominant model, instead of being modulated by strong environmental and genetic factors independent from HMBS. An oligogenic inheritance model with environmental modifiers might better explain AIP penetrance and heritability. |
Author | Deybach, Jean-Charles Lenglet, Hugo Nicolas, Gael Bouchet-Crivat, Florian Mirmiran, Arienne Karboul, Narjesse Simonin, Sylvie Schmitt, Caroline Gouya, Laurent Grange, Thomas Robreau, Anne-Marie Manceau, Hana Casalino, Enrique Puy, Hervé Lamoril, Jerôme Peoc'h, Katell Karim, Zoubida |
Author_xml | – sequence: 1 givenname: Hugo surname: Lenglet fullname: Lenglet, Hugo organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 2 givenname: Caroline surname: Schmitt fullname: Schmitt, Caroline organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 3 givenname: Thomas surname: Grange fullname: Grange, Thomas organization: INSERM UMR_S1048 Laboratory for Vascular Translational Science (LVTS) Université Paris Diderot, F-75018 Paris, France – sequence: 4 givenname: Hana surname: Manceau fullname: Manceau, Hana organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 5 givenname: Narjesse surname: Karboul fullname: Karboul, Narjesse organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 6 givenname: Florian surname: Bouchet-Crivat fullname: Bouchet-Crivat, Florian organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 7 givenname: Anne-Marie surname: Robreau fullname: Robreau, Anne-Marie organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 8 givenname: Gael surname: Nicolas fullname: Nicolas, Gael organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 9 givenname: Jerôme surname: Lamoril fullname: Lamoril, Jerôme organization: Département de Génétique, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Bichat, F-75018 Paris, France – sequence: 10 givenname: Sylvie surname: Simonin fullname: Simonin, Sylvie organization: Centre Français des Porphyries, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Louis Mourier, F-92701 Colombes, France – sequence: 11 givenname: Arienne surname: Mirmiran fullname: Mirmiran, Arienne organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 12 givenname: Zoubida surname: Karim fullname: Karim, Zoubida organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 13 givenname: Enrique surname: Casalino fullname: Casalino, Enrique organization: Département des Urgences, Assistance Publique-Hôpitaux de Paris, HUPNVS, Hôpital Bichat, F-75018 Paris, France – sequence: 14 givenname: Jean-Charles surname: Deybach fullname: Deybach, Jean-Charles organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 15 givenname: Hervé surname: Puy fullname: Puy, Hervé organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 16 givenname: Katell surname: Peoc'h fullname: Peoc'h, Katell organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France – sequence: 17 givenname: Laurent surname: Gouya fullname: Gouya, Laurent email: laurent.gouya@inserm.fr organization: UMRs 1149, Centre de Recherche sur l'Inflammation, Institut National de la Santé et de la Recherche Médicale, F-75018 Paris, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29360981$$D View this record in MEDLINE/PubMed https://hal.science/hal-02351445$$DView record in HAL |
BookMark | eNp90cFu1DAQBmALFdFt4cIDIF-QoFKonThOfKwqSpFW4gJny7EnG6PYDrZTtG-PV2k5oIqTR9b3z2H-C3TmgweE3lLyiRLRXE_ucG3MkTTkBdpRxklVk745QzsiOKu4IPwcXaT0kxDKWdO9Que1aDgRPd2heBeDwwqb4KxXPuMcsPI4zPYQDuCtxi4YmHEYsfUTRJuV14B_2zxh8A82Bu_AZzWfnB0txFQgVnrNUIYM0dmci8BLiMt0jFa9Ri9HNSd48_heoh93n7_f3lf7b1--3t7sK930Xa5aQ5RgQOuR66HnQ8cZ1CMzreLMDIbSgcHQkqYeAWoyNi0VQ99pDT2vTUehuUQft72TmuUSrVPxKIOy8v5mL09_pC4hxtoHWuyHzS4x_FohZels0jDPykNYk6RCkL6lnegKffdI18GB-bv56aYFkA3oGFKKMEpdrpZt8DkqO0tK5Kk2WWqTW20lcvVP5Gnrs_j9hsO6_M_9AaiZqAQ |
CitedBy_id | crossref_primary_10_3389_fgene_2023_1333111 crossref_primary_10_1016_j_rceng_2019_10_011 crossref_primary_10_3390_diagnostics12071618 crossref_primary_10_1080_23808993_2021_1838275 crossref_primary_10_1016_j_ymgmr_2018_07_007 crossref_primary_10_5582_irdr_2020_03082 crossref_primary_10_1002_2211_5463_13490 crossref_primary_10_2147_CEG_S348507 crossref_primary_10_1055_a_1282_1156 crossref_primary_10_1002_jmd2_12336 crossref_primary_10_1016_j_amjms_2021_03_004 crossref_primary_10_1111_joim_13463 crossref_primary_10_2147_DDDT_S281631 crossref_primary_10_1002_hep_30936 crossref_primary_10_1111_liv_16012 crossref_primary_10_1080_13696998_2020_1835306 crossref_primary_10_1016_j_ymgme_2018_09_002 crossref_primary_10_5005_jp_journals_10071_24133 crossref_primary_10_1007_s00108_018_0509_z crossref_primary_10_1016_j_ymgme_2018_10_008 crossref_primary_10_1002_jmd2_12281 crossref_primary_10_1097_MOG_0000000000000734 crossref_primary_10_1016_j_molmed_2018_11_003 crossref_primary_10_1053_j_gastro_2019_04_050 crossref_primary_10_1016_j_ymgme_2020_02_003 crossref_primary_10_1111_liv_15924 crossref_primary_10_1002_ajmg_a_62377 crossref_primary_10_1016_j_ymgme_2018_11_012 crossref_primary_10_1111_cge_13558 crossref_primary_10_1016_j_cgh_2022_09_022 crossref_primary_10_3390_diagnostics11091628 crossref_primary_10_1007_s40291_019_00438_6 crossref_primary_10_1055_s_0044_1787076 crossref_primary_10_3389_fgene_2024_1374965 crossref_primary_10_1038_s41390_018_0011_2 crossref_primary_10_1186_s13023_022_02314_9 crossref_primary_10_3390_metabo15020099 crossref_primary_10_1002_ajmg_a_63617 crossref_primary_10_1053_j_gastro_2022_11_034 crossref_primary_10_20344_amp_20323 crossref_primary_10_1002_jimd_12612 crossref_primary_10_3390_life13091923 crossref_primary_10_1016_j_rce_2019_10_012 crossref_primary_10_1016_j_ymgme_2018_12_006 crossref_primary_10_1016_j_jhep_2019_05_003 crossref_primary_10_1016_j_ymthe_2019_11_010 crossref_primary_10_1111_joim_13443 crossref_primary_10_1016_j_ymgmr_2022_100842 crossref_primary_10_3390_diagnostics11081343 crossref_primary_10_1016_j_rce_2024_04_003 crossref_primary_10_1016_j_ymgme_2022_01_002 crossref_primary_10_1016_j_rceng_2024_04_010 crossref_primary_10_1007_s00439_024_02680_3 crossref_primary_10_1016_S1245_1789_22_47082_X crossref_primary_10_1016_j_jhep_2022_05_018 crossref_primary_10_1016_j_ymgme_2018_10_001 crossref_primary_10_1016_j_ymgme_2018_12_010 crossref_primary_10_3390_biomedicines10030648 crossref_primary_10_1136_jclinpath_2021_207647 crossref_primary_10_3390_life12122059 crossref_primary_10_1002_ajmg_c_31619 crossref_primary_10_1016_j_ajhg_2023_08_012 crossref_primary_10_3390_diagnostics11101795 crossref_primary_10_1111_bph_15040 crossref_primary_10_1182_blood_2022018662 crossref_primary_10_1002_jimd_12809 crossref_primary_10_35754_0234_5730_2019_64_2_123_137 crossref_primary_10_1186_s13023_024_03287_7 crossref_primary_10_1055_a_2096_5899 crossref_primary_10_3390_ijms22020675 crossref_primary_10_1002_lt_25959 crossref_primary_10_1111_febs_16982 crossref_primary_10_7759_cureus_44260 |
Cites_doi | 10.1016/S0140-6736(09)61925-5 10.1034/j.1399-0004.2002.620406.x 10.1038/ki.2015.97 10.1016/j.clinre.2015.05.009 10.1002/1098-1004(200010)16:4<373::AID-HUMU14>3.0.CO;2-A 10.1007/s00439-002-0769-4 10.1136/jmg.32.12.979 10.1086/515455 10.1111/j.1365-2796.2011.02358.x 10.1093/hmg/4.2.215 10.1159/000459098 10.1002/humu.23067 10.1086/301844 10.1007/BF00420949 10.1172/JCI114869 10.1093/hmg/2.8.1315 10.1007/s10545-012-9544-4 10.1046/j.1365-2796.2000.00743.x 10.1093/bioinformatics/btv195 10.1007/BF03401859 10.1056/NEJM199806183382518 10.1007/BF00218912 10.1159/000067665 10.1007/s004390050480 10.1038/nmeth0410-248 10.1136/jclinpath-2012-200791 10.1042/BJ20082077 10.1046/j.1365-2796.1997.00189.x 10.1086/302729 |
ContentType | Journal Article |
Copyright | The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018 Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2018 – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
DOI | 10.1093/hmg/ddy030 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1460-2083 |
EndPage | 1173 |
ExternalDocumentID | oai_HAL_hal_02351445v1 29360981 10_1093_hmg_ddy030 10.1093/hmg/ddy030 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | France |
GeographicLocations_xml | – name: France |
GrantInformation_xml | – fundername: French National Research Agency grantid: ANR-11-IDEX-0005-02 funderid: 10.13039/501100001665 |
GroupedDBID | --- -DZ -E4 .2P .I3 .XZ .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAVLN ABEUO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPTD ABQLI ABWST ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFOFC AFXEN AGINJ AGKEF AGQXC AGSYK AHMBA AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APWMN ARIXL ATGXG AXUDD AYOIW BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM C45 CDBKE CS3 CZ4 DAKXR DIK DILTD DU5 D~K EBS EE~ EJD EMOBN F5P F9B FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M49 ML0 N9A NGC NLBLG NOMLY NOYVH NU- O9- OAWHX OBC OBOKY OBS OCZFY ODMLO OEB OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 RIG ROL ROX ROZ RUSNO RW1 RXO SJN TEORI TJX TLC TMA TR2 W8F WOQ X7H XSW YAYTL YKOAZ YXANX ZKX ~91 AAYXX ABDFA ABEJV ABGNP ABPQP ABVGC ABXZS ADNBA AFYAG AGORE AHMMS AJBYB AJNCP ALXQX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC |
ID | FETCH-LOGICAL-c387t-5d0a94e12f6cb86b764e2f4d5a64dbd11b4eb5032fee20f3519b87cce862d71e3 |
ISSN | 0964-6906 1460-2083 |
IngestDate | Fri May 09 12:08:31 EDT 2025 Fri Jul 11 07:05:46 EDT 2025 Wed Feb 19 02:32:32 EST 2025 Thu Jul 03 08:37:23 EDT 2025 Thu Apr 24 23:03:37 EDT 2025 Wed Sep 11 04:52:53 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices) Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c387t-5d0a94e12f6cb86b764e2f4d5a64dbd11b4eb5032fee20f3519b87cce862d71e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3724-5592 0000-0002-1671-8274 |
OpenAccessLink | https://academic.oup.com/hmg/article-pdf/27/7/1164/24398860/ddy030.pdf |
PMID | 29360981 |
PQID | 1990851797 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | hal_primary_oai_HAL_hal_02351445v1 proquest_miscellaneous_1990851797 pubmed_primary_29360981 crossref_citationtrail_10_1093_hmg_ddy030 crossref_primary_10_1093_hmg_ddy030 oup_primary_10_1093_hmg_ddy030 |
PublicationCentury | 2000 |
PublicationDate | 20180401 2018-04-01 |
PublicationDateYYYYMMDD | 2018-04-01 |
PublicationDate_xml | – month: 04 year: 2018 text: 20180401 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Human molecular genetics |
PublicationTitleAlternate | Hum Mol Genet |
PublicationYear | 2018 |
Publisher | Oxford University Press Oxford University Press (OUP) |
Publisher_xml | – name: Oxford University Press – name: Oxford University Press (OUP) |
References | Pallet ( key 20180319053713_ddy030-B10) 2015; 88 Puy ( key 20180319053713_ddy030-B1) 2010; 375 Almasy ( key 20180319053713_ddy030-B29) 1998; 62 Nordmann ( key 20180319053713_ddy030-B19) 1997; 242 Floderus ( key 20180319053713_ddy030-B4) 2002; 62 Stewart ( key 20180319053713_ddy030-B13) 2012; 65 Chen ( key 20180319053713_ddy030-B24) 2002; 111 Schuurmans ( key 20180319053713_ddy030-B17) 2001; 7 Puy ( key 20180319053713_ddy030-B2) 1997; 60 Elder ( key 20180319053713_ddy030-B6) 2013; 36 Andant ( key 20180319053713_ddy030-B9) 1998; 338 Exner ( key 20180319053713_ddy030-B25) 2001; 8 Llewellyn ( key 20180319053713_ddy030-B31) 1993; 2 Siervi ( key 20180319053713_ddy030-B32) 2000; 16 Adzhubei ( key 20180319053713_ddy030-B27) 2010; 7 Dar ( key 20180319053713_ddy030-B7) 2010; 9 Anderson ( key 20180319053713_ddy030-B26) 1982; 28 Di Pierro ( key 20180319053713_ddy030-B16) 2006; 119 Kauppinen ( key 20180319053713_ddy030-B15) 1995; 4 Falconer ( key 20180319053713_ddy030-B30) 1996 Karim ( key 20180319053713_ddy030-B12) 2015; 39 Andersson ( key 20180319053713_ddy030-B11) 2000; 248 Delfau ( key 20180319053713_ddy030-B14) 1990; 86 Kimpara ( key 20180319053713_ddy030-B22) 1997; 100 Choi ( key 20180319053713_ddy030-B28) 2015; 31 Hrdinka ( key 20180319053713_ddy030-B18) 2006; 55 (Suppl. 2) Mgone ( key 20180319053713_ddy030-B33) 1993; 92 Lundin ( key 20180319053713_ddy030-B34) 1995; 32 Deybach ( key 20180319053713_ddy030-B8) 2011; 269 Yamada ( key 20180319053713_ddy030-B23) 2000; 66 Schneider-Yin ( key 20180319053713_ddy030-B5) 2002; 54 Gu ( key 20180319053713_ddy030-B3) 1994; 93 Chen ( key 20180319053713_ddy030-B20) 2016; 37 Gill ( key 20180319053713_ddy030-B21) 2009; 420 |
References_xml | – volume: 375 start-page: 924 year: 2010 ident: key 20180319053713_ddy030-B1 article-title: Porphyrias publication-title: Lancet doi: 10.1016/S0140-6736(09)61925-5 – volume: 62 start-page: 288 year: 2002 ident: key 20180319053713_ddy030-B4 article-title: Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene publication-title: Clin. Genet doi: 10.1034/j.1399-0004.2002.620406.x – volume: 119 start-page: 364 year: 2006 ident: key 20180319053713_ddy030-B16 article-title: Gene symbol: HMBS. Disease: porphyria, acute intermittent publication-title: Hum. Genet – volume-title: Introduction to Quantitative Genetics year: 1996 ident: key 20180319053713_ddy030-B30 – volume: 88 start-page: 386 year: 2015 ident: key 20180319053713_ddy030-B10 article-title: High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria publication-title: Kidney Int doi: 10.1038/ki.2015.97 – volume: 39 start-page: 412 year: 2015 ident: key 20180319053713_ddy030-B12 article-title: Porphyrias: a 2015 update publication-title: Clin. Res. Hepatol. Gastroenterol doi: 10.1016/j.clinre.2015.05.009 – volume: 8 start-page: 433 year: 2001 ident: key 20180319053713_ddy030-B25 article-title: Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty publication-title: J. Endovasc. Ther. Off. J. Int. Soc. Endovasc. Spec – volume: 16 start-page: 373. year: 2000 ident: key 20180319053713_ddy030-B32 article-title: Identification and characterization of two novel mutations that produce acute intermittent porphyria: a 3-base deletion (841-843delGGA) and a missense mutation (T35M) publication-title: Hum. Mutat doi: 10.1002/1098-1004(200010)16:4<373::AID-HUMU14>3.0.CO;2-A – volume: 111 start-page: 1 year: 2002 ident: key 20180319053713_ddy030-B24 article-title: Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients publication-title: Hum. Genet doi: 10.1007/s00439-002-0769-4 – volume: 9 start-page: 93 year: 2010 ident: key 20180319053713_ddy030-B7 article-title: Liver transplantation for acute intermittent porphyria: a viable treatment? publication-title: Hepatobiliary Pancreat. Dis. Int – volume: 32 start-page: 979 year: 1995 ident: key 20180319053713_ddy030-B34 article-title: Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria publication-title: J. Med. Genet doi: 10.1136/jmg.32.12.979 – volume: 60 start-page: 1373 year: 1997 ident: key 20180319053713_ddy030-B2 article-title: Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria publication-title: Am. J. Hum. Genet doi: 10.1086/515455 – volume: 269 start-page: 521 year: 2011 ident: key 20180319053713_ddy030-B8 article-title: Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa publication-title: J. Intern. Med doi: 10.1111/j.1365-2796.2011.02358.x – volume: 4 start-page: 215 year: 1995 ident: key 20180319053713_ddy030-B15 article-title: Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene publication-title: Hum. Mol. Genet doi: 10.1093/hmg/4.2.215 – volume: 28 start-page: 146 year: 1982 ident: key 20180319053713_ddy030-B26 article-title: Porphobilinogen deaminase: methods and principles of the enzymatic assay publication-title: Enzyme doi: 10.1159/000459098 – volume: 37 start-page: 1215 year: 2016 ident: key 20180319053713_ddy030-B20 article-title: Acute intermittent porphyria: predicted pathogenicity of HMBS variants indicates extremely low penetrance of the autosomal dominant disease publication-title: Hum. Mutat doi: 10.1002/humu.23067 – volume: 62 start-page: 1198 year: 1998 ident: key 20180319053713_ddy030-B29 article-title: Multipoint quantitative-trait linkage analysis in general pedigrees publication-title: Am. J. Hum. Genet doi: 10.1086/301844 – volume: 92 start-page: 619 year: 1993 ident: key 20180319053713_ddy030-B33 article-title: Detection of a high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyria publication-title: Hum. Genet doi: 10.1007/BF00420949 – volume: 86 start-page: 1511 year: 1990 ident: key 20180319053713_ddy030-B14 article-title: Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria publication-title: J. Clin. Invest doi: 10.1172/JCI114869 – volume: 2 start-page: 1315 year: 1993 ident: key 20180319053713_ddy030-B31 article-title: Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase publication-title: Hum. Mol. Genet doi: 10.1093/hmg/2.8.1315 – volume: 36 start-page: 849 year: 2013 ident: key 20180319053713_ddy030-B6 article-title: The incidence of inherited porphyrias in Europe publication-title: J. Inherit. Metab. Dis doi: 10.1007/s10545-012-9544-4 – volume: 248 start-page: 319 year: 2000 ident: key 20180319053713_ddy030-B11 article-title: Renal symptomatology in patients with acute intermittent porphyria. A population-based study publication-title: J. Intern. Med doi: 10.1046/j.1365-2796.2000.00743.x – volume: 31 start-page: 2745 year: 2015 ident: key 20180319053713_ddy030-B28 article-title: PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels publication-title: Bioinforma. Oxf. Engl doi: 10.1093/bioinformatics/btv195 – volume: 7 start-page: 535 year: 2001 ident: key 20180319053713_ddy030-B17 article-title: Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients publication-title: Mol. Med. Camb. Mass doi: 10.1007/BF03401859 – volume: 338 start-page: 1853 year: 1998 ident: key 20180319053713_ddy030-B9 article-title: Acute hepatic porphyrias and primary liver cancer publication-title: N. Engl. J. Med doi: 10.1056/NEJM199806183382518 – volume: 93 start-page: 47 year: 1994 ident: key 20180319053713_ddy030-B3 article-title: Detection of eleven mutations causing acute intermittent porphyria using denaturing gradient gel electrophoresis publication-title: Hum. Genet doi: 10.1007/BF00218912 – volume: 54 start-page: 69 year: 2002 ident: key 20180319053713_ddy030-B5 article-title: Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients publication-title: Hum. Hered doi: 10.1159/000067665 – volume: 100 start-page: 145 year: 1997 ident: key 20180319053713_ddy030-B22 article-title: Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease publication-title: Hum. Genet doi: 10.1007/s004390050480 – volume: 7 start-page: 248 year: 2010 ident: key 20180319053713_ddy030-B27 article-title: A method and server for predicting damaging missense mutations publication-title: Nat. Methods doi: 10.1038/nmeth0410-248 – volume: 65 start-page: 976 year: 2012 ident: key 20180319053713_ddy030-B13 article-title: Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up publication-title: J. Clin. Pathol doi: 10.1136/jclinpath-2012-200791 – volume: 420 start-page: 17 year: 2009 ident: key 20180319053713_ddy030-B21 article-title: Structure of human porphobilinogen deaminase at 2.8 A: the molecular basis of acute intermittent porphyria publication-title: Biochem. J doi: 10.1042/BJ20082077 – volume: 55 (Suppl. 2) start-page: S119 year: 2006 ident: key 20180319053713_ddy030-B18 article-title: May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population publication-title: Physiol. Res. Acad. Sci. Bohemoslov – volume: 242 start-page: 213 year: 1997 ident: key 20180319053713_ddy030-B19 article-title: Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France publication-title: J. Intern. Med doi: 10.1046/j.1365-2796.1997.00189.x – volume: 66 start-page: 187 year: 2000 ident: key 20180319053713_ddy030-B23 article-title: Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema publication-title: Am. J. Hum. Genet doi: 10.1086/302729 |
SSID | ssj0016437 |
Score | 2.531762 |
Snippet | Abstract
Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS)... Acute intermittent porphyria (AIP) is a disease affecting the heme biosynthesis pathway caused by mutations of the hydroxymethylbilane synthase (HMBS) gene.... |
SourceID | hal proquest pubmed crossref oup |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1164 |
SubjectTerms | Databases, Nucleic Acid Endocrinology and metabolism Female France France - epidemiology Gene-Environment Interaction Genetics Hematology Human genetics Human health and pathology Humans Hydroxymethylbilane Synthase Hydroxymethylbilane Synthase - genetics Hépatology and Gastroenterology Infectious diseases Life Sciences Male Mutation, Missense Penetrance Porphyria, Acute Intermittent Porphyria, Acute Intermittent - enzymology Porphyria, Acute Intermittent - epidemiology Porphyria, Acute Intermittent - genetics Prevalence Tissues and Organs Urology and Nephrology |
Title | From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29360981 https://www.proquest.com/docview/1990851797 https://hal.science/hal-02351445 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEIgXBONWLpO5vCAUFufaPFYbpWPdNIlV2lsUx05bqU2mkiKNP81f4ByfJE1ZNQ1eoip1I7fnq318Lt_H2AfHDlLcJiw3izLLk4ljSU9EViCFdhJPOpEhez45DYZj79uFf9Hp_G5VLa1K-Tn9tbWv5H-sCvfArtgl-w-WbR4KN-A12BeuYGG43srGA-wNST6pgupZ0I9EpYn5bFLAZ2Yp6dwQKwT2-ZWmP8CEXlsNbtg_UqhZhqLYGP5IUqwdQB4JbPYvsVgAnHQwB1UkN74sxf8Xtb4uijFjR2TjpI90PplTrmO4mhTrlM90UaWkDkgzqMHW1yW2OvxVt2TC5TDvZGWelJDcdx2pEL1WgcsNHZCGVnV8Vgc-quBk4FlIoUy7FC3NXmCD9Un2pl67iVegwmjYWoiFIHL0alMXggRTrm0YRKY1XcC6OlDqyqYkUQs7lwsDHvCKAjsidZlN1u5h_3t8djiIR0enx5vvNvTdw_4ongK6kFsIDrD-Tziu33XgXIOSG4dHx03aC7Oohhyy-vo1n27k7sMU92mCyF9dzWbDmbozxVLejTbNa6cl4zWdP2IPq-MO7xN2H7OOznfZPRJAvdpl90-q0o4nbIlg5gmvwczLgic5X4OZGzDzIuMtMHMEM98AM2_ADAO5ATNvg5k3YH7KxoMv5wdDqxIEsVK3F5aWr-wk8rRwsiCVvUCGgaedzFN-EnhKKiGkp6Vvu06mtWNnqD0pe2Gaaji2q1Bo9xnbyYtcv2BcBVpH4IpnjtJearuRUsJWvur5Sjqh9LvsY_3LxmnFlo-iLfOYqjbcGAwSk0G67H0z9pI4YraOeocYqAdsx0WX7YH9bnzK29q0MWwEmN1Lcl2sfsQC_MoeEu6FXfacbN48p8bLy9vM4RV7sP73vmY75XKl34DnXco9g9Y_AMPdmg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=From+a+dominant+to+an+oligogenic+model+of+inheritance+with+environmental+modifiers+in+acute+intermittent+porphyria&rft.jtitle=Human+molecular+genetics&rft.au=Lenglet%2C+Hugo&rft.au=Schmitt%2C+Caroline&rft.au=Grange%2C+Thomas&rft.au=Manceau%2C+Hana&rft.date=2018-04-01&rft.pub=Oxford+University+Press+%28OUP%29&rft.issn=0964-6906&rft.eissn=1460-2083&rft.volume=27&rft.issue=7&rft.spage=1164&rft.epage=1173&rft_id=info:doi/10.1093%2Fhmg%2Fddy030&rft_id=info%3Apmid%2F29360981&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=oai_HAL_hal_02351445v1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0964-6906&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0964-6906&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0964-6906&client=summon |